Literature DB >> 29771274

Identification of Chronic Obstructive Pulmonary Disease Axes That Predict All-Cause Mortality: The COPDGene Study.

Gregory L Kinney1, Stephanie A Santorico2,3,4, Kendra A Young1, Michael H Cho5, Peter J Castaldi5, Raul San José Estépar5, James C Ross5, Jennifer G Dy6, Barry J Make7, Elizabeth A Regan7, David A Lynch8, Douglas C Everett4, Sharon M Lutz9, Edwin K Silverman5, George R Washko5, James D Crapo7, John E Hokanson1.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a syndrome caused by damage to the lungs that results in decreased pulmonary function and reduced structural integrity. Pulmonary function testing (PFT) is used to diagnose and stratify COPD into severity groups, and computed tomography (CT) imaging of the chest is often used to assess structural changes in the lungs. We hypothesized that the combination of PFT and CT phenotypes would provide a more powerful tool for assessing underlying morphologic differences associated with pulmonary function in COPD than does PFT alone. We used factor analysis of 26 variables to classify 8,157 participants recruited into the COPDGene cohort between January 2008 and June 2011 from 21 clinical centers across the United States. These factors were used as predictors of all-cause mortality using Cox proportional hazards modeling. Five factors explained 80% of the covariance and represented the following domains: factor 1, increased emphysema and decreased pulmonary function; factor 2, airway disease and decreased pulmonary function; factor 3, gas trapping; factor 4, CT variability; and factor 5, hyperinflation. After more than 46,079 person-years of follow-up, factors 1 through 4 were associated with mortality and there was a significant synergistic interaction between factors 1 and 2 on death. Considering CT measures along with PFT in the assessment of COPD can identify patients at particularly high risk for death.

Entities:  

Mesh:

Year:  2018        PMID: 29771274      PMCID: PMC6166205          DOI: 10.1093/aje/kwy087

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  15 in total

1.  A RATIONALE AND TEST FOR THE NUMBER OF FACTORS IN FACTOR ANALYSIS.

Authors:  J L HORN
Journal:  Psychometrika       Date:  1965-06       Impact factor: 2.500

2.  Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts.

Authors:  Peter J Castaldi; Marta Benet; Hans Petersen; Nicholas Rafaels; James Finigan; Matteo Paoletti; H Marike Boezen; Judith M Vonk; Russell Bowler; Massimo Pistolesi; Milo A Puhan; Josep Anto; Els Wauters; Diether Lambrechts; Wim Janssens; Francesca Bigazzi; Gianna Camiciottoli; Michael H Cho; Craig P Hersh; Kathleen Barnes; Stephen Rennard; Meher Preethi Boorgula; Jennifer Dy; Nadia N Hansel; James D Crapo; Yohannes Tesfaigzi; Alvar Agusti; Edwin K Silverman; Judith Garcia-Aymerich
Journal:  Thorax       Date:  2017-06-21       Impact factor: 9.139

3.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

4.  Association between airway caliber changes with lung inflation and emphysema assessed by volumetric CT scan in subjects with COPD.

Authors:  Alejandro A Diaz; Carolyn E Come; James C Ross; Raúl San José Estépar; MeiLan K Han; Stephen H Loring; Edwin K Silverman; George R Washko
Journal:  Chest       Date:  2011-09-22       Impact factor: 9.410

5.  Automated telecommunication to obtain longitudinal follow-up in a multicenter cross-sectional COPD study.

Authors:  Jeffrey I Stewart; Sarah Moyle; Gerard J Criner; Carla Wilson; Ron Tanner; Russell P Bowler; James D Crapo; Robert K Zeldin; Barry J Make; Elizabeth A Regan
Journal:  COPD       Date:  2012-06-07       Impact factor: 2.409

6.  Developing COPD: a 25 year follow up study of the general population.

Authors:  A Løkke; P Lange; H Scharling; P Fabricius; J Vestbo
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

Review 7.  Exacerbations in chronic obstructive pulmonary disease: do they contribute to disease progression?

Authors:  Edwin K Silverman
Journal:  Proc Am Thorac Soc       Date:  2007-12

Review 8.  Phenotypes of chronic obstructive pulmonary disease.

Authors:  Adam L Friedlander; David Lynch; Liesel A Dyar; Russell P Bowler
Journal:  COPD       Date:  2007-12       Impact factor: 2.409

9.  CT metrics of airway disease and emphysema in severe COPD.

Authors:  Woo Jin Kim; Edwin K Silverman; Eric Hoffman; Gerard J Criner; Zab Mosenifar; Frank C Sciurba; Barry J Make; Vincent Carey; Raúl San José Estépar; Alejandro Diaz; John J Reilly; Fernando J Martinez; George R Washko
Journal:  Chest       Date:  2009-05-01       Impact factor: 9.410

10.  Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes.

Authors:  Meilan K Han; Ella A Kazerooni; David A Lynch; Lyrica X Liu; Susan Murray; Jeffrey L Curtis; Gerard J Criner; Victor Kim; Russell P Bowler; Nicola A Hanania; Antonio R Anzueto; Barry J Make; John E Hokanson; James D Crapo; Edwin K Silverman; Fernando J Martinez; George R Washko
Journal:  Radiology       Date:  2011-07-25       Impact factor: 11.105

View more
  13 in total

1.  Turning subtypes into disease axes to improve prediction of COPD progression.

Authors:  Junxiang Chen; Michael Cho; Edwin K Silverman; John E Hokanson; Greg L Kinney; James D Crapo; Stephen Rennard; Jennifer Dy; Peter Castaldi
Journal:  Thorax       Date:  2019-06-12       Impact factor: 9.139

Review 2.  Machine Learning Characterization of COPD Subtypes: Insights From the COPDGene Study.

Authors:  Peter J Castaldi; Adel Boueiz; Jeong Yun; Raul San Jose Estepar; James C Ross; George Washko; Michael H Cho; Craig P Hersh; Gregory L Kinney; Kendra A Young; Elizabeth A Regan; David A Lynch; Gerald J Criner; Jennifer G Dy; Stephen I Rennard; Richard Casaburi; Barry J Make; James Crapo; Edwin K Silverman; John E Hokanson
Journal:  Chest       Date:  2019-12-28       Impact factor: 9.410

3.  Letter to the Editor: Response by Authors.

Authors:  Katherine E Lowe; John E Hokanson; Barry J Make; Katherine A Pratte; Elizabeth A Regan; Edwin K Silverman; Kendra A Young; Gregory L Kinney; James D Crapo
Journal:  Chronic Obstr Pulm Dis       Date:  2020-04

4.  Triple therapy for COPD: a crude analysis from a systematic review of the evidence.

Authors:  Jose Luis Lopez-Campos; Laura Carrasco-Hernandez; Esther Quintana-Gallego; Carmen Calero-Acuña; Eduardo Márquez-Martín; Francisco Ortega-Ruiz; Joan B Soriano
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

5.  Pulmonary Subtypes Exhibit Differential Global Initiative for Chronic Obstructive Lung Disease Spirometry Stage Progression: The COPDGene® Study.

Authors:  Kendra A Young; Matthew Strand; Margaret F Ragland; Gregory L Kinney; Erin E Austin; Elizabeth A Regan; Katherine E Lowe; Barry J Make; Edwin K Silverman; James D Crapo; John E Hokanson
Journal:  Chronic Obstr Pulm Dis       Date:  2019-11

6.  Subtypes of COPD Have Unique Distributions and Differential Risk of Mortality.

Authors:  Kendra A Young; Elizabeth A Regan; MeiLan K Han; Sharon M Lutz; Margaret Ragland; Peter J Castaldi; George R Washko; Michael H Cho; Mathew Strand; Douglas Curran-Everett; Terri H Beaty; Russell P Bowler; Emily S Wan; David A Lynch; Barry J Make; Edwin K Silverman; James D Crapo; John E Hokanson; Gregory L Kinney
Journal:  Chronic Obstr Pulm Dis       Date:  2019-11

7.  COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease.

Authors:  Katherine E Lowe; Elizabeth A Regan; Antonio Anzueto; Erin Austin; John H M Austin; Terri H Beaty; Panayiotis V Benos; Christopher J Benway; Surya P Bhatt; Eugene R Bleecker; Sandeep Bodduluri; Jessica Bon; Aladin M Boriek; Adel Re Boueiz; Russell P Bowler; Matthew Budoff; Richard Casaburi; Peter J Castaldi; Jean-Paul Charbonnier; Michael H Cho; Alejandro Comellas; Douglas Conrad; Corinne Costa Davis; Gerard J Criner; Douglas Curran-Everett; Jeffrey L Curtis; Dawn L DeMeo; Alejandro A Diaz; Mark T Dransfield; Jennifer G Dy; Ashraf Fawzy; Margaret Fleming; Eric L Flenaugh; Marilyn G Foreman; Spyridon Fortis; Hirut Gebrekristos; Sarah Grant; Philippe A Grenier; Tian Gu; Abhya Gupta; MeiLan K Han; Nicola A Hanania; Nadia N Hansel; Lystra P Hayden; Craig P Hersh; Brian D Hobbs; Eric A Hoffman; James C Hogg; John E Hokanson; Karin F Hoth; Albert Hsiao; Stephen Humphries; Kathleen Jacobs; Francine L Jacobson; Ella A Kazerooni; Victor Kim; Woo Jin Kim; Gregory L Kinney; Harald Koegler; Sharon M Lutz; David A Lynch; Neil R MacIntye; Barry J Make; Nathaniel Marchetti; Fernando J Martinez; Diego J Maselli; Anne M Mathews; Meredith C McCormack; Merry-Lynn N McDonald; Charlene E McEvoy; Matthew Moll; Sarah S Molye; Susan Murray; Hrudaya Nath; John D Newell; Mariaelena Occhipinti; Matteo Paoletti; Trisha Parekh; Massimo Pistolesi; Katherine A Pratte; Nirupama Putcha; Margaret Ragland; Joseph M Reinhardt; Stephen I Rennard; Richard A Rosiello; James C Ross; Harry B Rossiter; Ingo Ruczinski; Raul San Jose Estepar; Frank C Sciurba; Jessica C Sieren; Harjinder Singh; Xavier Soler; Robert M Steiner; Matthew J Strand; William W Stringer; Ruth Tal-Singer; Byron Thomashow; Gonzalo Vegas Sánchez-Ferrero; John W Walsh; Emily S Wan; George R Washko; J Michael Wells; Chris H Wendt; Gloria Westney; Ava Wilson; Robert A Wise; Andrew Yen; Kendra Young; Jeong Yun; Edwin K Silverman; James D Crapo
Journal:  Chronic Obstr Pulm Dis       Date:  2019-11

8.  [Lung sounds can be used as an indicator for assessing severity of chronic obstructive pulmonary disease at the initial diagnosis].

Authors:  Shifeng Chen; Minyu Huang; Xianru Peng; Yafei Yuan; Shuyu Huang; Yanmei Ye; Wenqu Zhao; Bohou Li; Huishan Han; Shuluan Yang; Shaoxi Cai; Haijin Zhao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-02-29

9.  When Harry Met Sally, or When Machine Learning Met Chronic Obstructive Pulmonary Disease.

Authors:  Alvar Agusti; Rosa Faner
Journal:  Am J Respir Crit Care Med       Date:  2020-02-01       Impact factor: 21.405

10.  Co-Morbidity Patterns Identified Using Latent Class Analysis of Medications Predict All-Cause Mortality Independent of Other Known Risk Factors: The COPDGene® Study.

Authors:  Yisha Li; Margaret Ragland; Erin Austin; Kendra Young; Katherine Pratte; John E Hokanson; Terri H Beaty; Elizabeth A Regan; Stephen I Rennard; Christina Wern; Michael R Jacobs; Ruth Tal-Singer; Barry J Make; Gregory L Kinney
Journal:  Clin Epidemiol       Date:  2020-10-27       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.